Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd cash flow reinvestment rate. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥3.65 Million (capex CN¥3.65 Million ) from operating cash flow of CN¥43.77 Million. Explore Shanghai Fudan-Zhangjiang Bio-Pharmaceut cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2009–2025)
Cash flow reinvestment rate of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2009 to 2025. Historical reinvestment intensity for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd across 15 annual periods. Explore 688505 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2009–2025)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | CN¥51.70 Million | CN¥141.40 Million | CN¥32.37 Million | ▼ -82.9% |
| 2023 | 2.14x | CN¥151.88 Million | CN¥71.02 Million | CN¥98.97 Million | ▲ +92.0% |
| 2022 | 1.11x | CN¥184.05 Million | CN¥165.27 Million | CN¥87.30 Million | ▼ -37.1% |
| 2021 | 1.77x | CN¥475.79 Million | CN¥268.90 Million | CN¥120.12 Million | ▲ +124.8% |
| 2020 | 0.79x | CN¥88.95 Million | CN¥113.00 Million | CN¥42.41 Million | ▲ +244.4% |
| 2019 | 0.23x | CN¥61.53 Million | CN¥269.23 Million | CN¥40.39 Million | ▲ +5.2% |
| 2018 | 0.22x | CN¥37.79 Million | CN¥173.94 Million | CN¥37.79 Million | ▼ -84.8% |
| 2017 | 1.43x | CN¥60.94 Million | CN¥42.71 Million | CN¥60.94 Million | ▲ +328.4% |
| 2016 | 0.33x | CN¥46.82 Million | CN¥140.57 Million | CN¥46.82 Million | ▼ -19.3% |
| 2015 | 0.41x | CN¥39.75 Million | CN¥96.30 Million | CN¥39.75 Million | ▼ -18.8% |
| 2014 | 0.51x | CN¥44.91 Million | CN¥88.36 Million | CN¥44.91 Million | ▼ -20.8% |
| 2013 | 0.64x | CN¥57.38 Million | CN¥89.44 Million | CN¥57.38 Million | ▼ -38.4% |
| 2012 | 1.04x | CN¥114.69 Million | CN¥110.19 Million | CN¥114.69 Million | ▲ +56.5% |
| 2011 | 0.67x | CN¥32.99 Million | CN¥49.59 Million | CN¥32.99 Million | ▼ -90.8% |
| 2009 | 7.23x | CN¥55.82 Million | CN¥7.72 Million | CN¥55.82 Million | — |